Trial Details
TERMINATEDBasic Information
| Clinical ID | c1594 |
|---|---|
| Identifier | NCT03923478 |
| Trial Title | ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis Chronic Mild|Ulcerative Colitis Chronic Moderate |
| Interventions | DRUG: ABI-M201|DRUG: Placebo |
Participant Information
| Sponsor | Assembly Biosciences |
|---|---|
| City | Oakland |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2019-06-24 |
|---|---|
| Primary Completion Date | 2021-01-20 |
| Completion Date | 2021-01-20 |